129 related articles for article (PubMed ID: 21620804)
1. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
[TBL] [Abstract][Full Text] [Related]
2. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
[TBL] [Abstract][Full Text] [Related]
3. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
4. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
5. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Varani K; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Benini A; Klotz KN; Baraldi PG; Tabrizi MA; Lennan SM; Leung E; Borea PA
Biochem Pharmacol; 2005 Nov; 70(11):1601-12. PubMed ID: 16219300
[TBL] [Abstract][Full Text] [Related]
7. Role of extracellular cysteine residues in the adenosine A2A receptor.
De Filippo E; Namasivayam V; Zappe L; El-Tayeb A; Schiedel AC; Müller CE
Purinergic Signal; 2016 Jun; 12(2):313-29. PubMed ID: 26969588
[TBL] [Abstract][Full Text] [Related]
8. Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.
Beukers MW; van Oppenraaij J; van der Hoorn PP; Blad CC; den Dulk H; Brouwer J; IJzerman AP
Mol Pharmacol; 2004 Mar; 65(3):702-10. PubMed ID: 14978249
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
[TBL] [Abstract][Full Text] [Related]
10. Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling.
Liu R; Nahon D; le Roy B; Lenselink EB; IJzerman AP
Biochem Pharmacol; 2015 Jun; 95(4):290-300. PubMed ID: 25896847
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
[TBL] [Abstract][Full Text] [Related]
12. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
Hinz S; Lacher SK; Seibt BF; Müller CE
J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
15. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
[TBL] [Abstract][Full Text] [Related]
16. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
[TBL] [Abstract][Full Text] [Related]
17. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2.
Schulte G; Fredholm BB
Mol Pharmacol; 2000 Sep; 58(3):477-82. PubMed ID: 10953039
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.
Ehrlich GK; Andria ML; Zheng X; Kieffer B; Gioannini TL; Hiller JM; Rosenkranz JE; Veksler BM; Zukin RS; Simon EJ
Can J Physiol Pharmacol; 1998 Mar; 76(3):269-77. PubMed ID: 9673790
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
Wang CD; Buck MA; Fraser CM
Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
[TBL] [Abstract][Full Text] [Related]
20. Distinct binding mode of 125I-AngII to AT1 receptor without the Cys18-Cys274 disulfide bridge.
Martin RP; Rodrigues ES; Pacheco NA; Corrêa SA; Oliveira SM; Oliveira L; Nakaie CR; Shimuta SI
Regul Pept; 2009 Nov; 158(1-3):14-8. PubMed ID: 19651161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
